Amanda E. Faulkner, MPH Surveillance Coordinator 2011 National Immunization Conference March 30, 2011 Zooming in on Pertussis Epidemiology in the United.

Slides:



Advertisements
Similar presentations
Nancy Gathany, PhD & Rhonda Willis, MBA OSELS/Educational Design and Accreditation Branch MedBiquitous Annual Meeting April 9, 2013 Office of Surveillance,
Advertisements

Dr. Koku Kazaura, Prevention Team Lead, CDC - Tanzania
Underestimating the burden of pertussis in WA 2011 CSTE Annual Meeting Pittsburgh, PA Chas DeBolt RN, MPH Azadeh Tasslimi, MPH Washington State Department.
Rabies Surveillance in the United States During 2012 Division of High-Consequence Pathogens and Pathology Poxvirus and Rabies Branch March 2014 National.
Role of Health Information Technology in Nationwide Outbreaks Chesley Richards, MD, MPH Director, Office of Public Health Scientific Services Centers for.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2009 Division of STD Prevention.
Brandi Cooke Student Intern 3 rd National Summit on Preconception Health and Health Care June 12-14, 2011 Factors Affecting the Willingness of Counselors.
Endeavors in Transportation Health Impact Assessment LCDR Joseph Ralph, MPH, CHES Healthy Community Design Initiative June 2015 National Center for Environmental.
Birth Certificate and Hospital Discharge Linkage Survey: Results from 52 jurisdictions Shin Y. Kim 1, Sukhjeet Ahuja 2, Caroline Stampfel 3, Dhelia Williamson.
Assessment of Program Evaluation Activities in Tuberculosis Control Programs — United States, 2009–2010 Silvia M. Trigoso, MPH Fellow, Public Health Prevention.
Presentation Title Presenter(s) Centers for Disease Control and Prevention AIDS Turning the Tide Together.
Meredith Carr, JD J. Stan Lehman, MPH David W. Purcell, JD, PhD Division of HIV/AIDS Prevention Centers for Disease Control and Prevention July 25, 2012.
Kirk Smith MN, Carina Blackmore FL, John Dunn TN, Alicia Cronquist CO, Bill Keene OR Dale Morse & Don Sharp CDC CSTE Annual Meeting June 12, 2013 National.
Nedra Garrett Director, Division of Informatics Practice, Policy, and Coordination (DIPPC) PHIN Partner Call April 20, 2011 Public Health Information Network.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention HIV testing among transgender persons funded by the.
Office of Epidemiology and Prevention Services Division of Infectious Disease Epidemiology Identification of a Pseudo-Epidemic of Pertussis.
James W. Buehler, MD Director, Public Health Surveillance Program Office, OSELS, CDC CSTE Annual Conference June 13, 2011 Pittsburgh, PA Public Health.
Harold H. Collins Information Technology Specialist Epi Info™ Background Korean Public Health Surveillance Conference 30 March 2011 Epi Info™ Background.
Sexually Transmitted Disease Surveillance 2012 Division of STD Prevention.
Pertussis and Adolescents: It’s Time for a Boost A Slide Kit for School Nurses.
Decreasing Incidence of Pertussis in Massachusetts Following the Introduction of Tdap Noelle Cocoros, Nancy Harrington, Rosa Hernandez, Jennifer Myers,
National Surveillance Estimates of Unintentional, Non-fire Related Carbon Monoxide Poisoning Jackie Clower, MPH Contractor, Air Pollution & Respiratory.
Public Health Birth Defects Surveillance
Office of Public Health Preparedness and Response Division of Strategic National Stockpile Ben Erickson Public Health Analyst Inventory Management Tracking,
June 2010 California Pertussis Update. Pertussis Background Pertussis is the most poorly controlled vaccine- preventable disease  Incidence increasing.
Investigation of the Hald model as a method to improve foodborne illness source attribution estimates Antonio Vieira, DVM, MPH, PhD Enteric Diseases Epidemiology.
Thomas Clark, MD, MPH Centers for Disease Control and Prevention Immunization Program Managers Meeting November 16, 2010 Pertussis Epidemiology in the.
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
National Mortality Surveillance: Building a Foundation Paul D. Sutton, Ph.D. Mortality Surveillance Team Lead NAPHSIS/NCHS Joint Meeting Phoenix, Arizona.
Center for Surveillance, Epidemiology, and Laboratory Services Division of Health Informatics and Surveillance Demonstration and Workshop Highlighting.
Epidemiology of Tuberculosis in Correctional Facilities, United States, Surveillance, Epidemiology and Outbreak Investigations Branch Division.
Principles of Planning Mark Keim, MD Senior Science Advisor DHHS Integrated Training Summit May 22, 2012 National Center for Environmental Health Agency.
Public Health Response to Traumatic Brain Injury
Infection Prevention in US Outpatient Oncology Settings Alice Guh, MD. MPH National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare.
STDs in Persons Entering Corrections Facilities Sexually Transmitted Disease Surveillance 2009 Division of STD Prevention.
Course Title: Using Epi Info™ 7 Using Classic Analysis (Continuation) April Epi Info™ 7 Training Software for Public Health Epi Info™ 7 Training.
Poxvirus and Rabies Branch November 2011 Rabies Surveillance in the United States During 2010 Division of High-Consequence Pathogens and Pathology National.
Sexually Transmitted Disease Surveillance 2012 Division of STD Prevention.
José Aponte Public Health Advisor Module 7: Mapping 12 June 2012 Epi Info™ 7 Introductory Training Office of Surveillance, Epidemiology, and Laboratory.
STDs in Women and Infants Sexually Transmitted Disease Surveillance 2009 Division of STD Prevention.
Measuring Healthy Life Expectancy for the U.S. Population in Man-Huei Chang, MPH Division of Epidemiologic and Analytic Methods for Population.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
* Centers for Disease Control and Prevention. Health Education Curriculum Analysis Tool. Atlanta, GA: U.S. Department of Health and Human Services; 2011.
Tetanus Surveillance and Epidemiology in the United States, CDC, Atlanta, GA 1 National Immunization Conference Atlanta, GA April 20, 2010 C.
| Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official.
National Center for Emerging and Zoonotic Infectious Diseases Division of High-Consequence Pathogens and Pathology Rabies Surveillance in the United States.
Rabies Surveillance in the United States During 2013 Division of High-Consequence Pathogens and Pathology Poxvirus and Rabies Branch December 2015 National.
Alfred Junior, MPH Lindsey Weiner, MPH Scott Fridkin, MD Division of Healthcare Quality Promotion CDC November 18, 2015 Notes From the Field: Antibiotic.
Jennifer Rittenhouse Cope, MD EIS Officer North Dakota Department of Health Factors Associated with Tdap and Meningococcal Vaccination Coverage Among Middle.
An Evaluation of Vaccine-specific Exemptions in Multnomah County, Oregon Kelly McCarthy Howard PHAP Public Health Associate Office for State, Tribal, Local.
Where Has All the Pertussis Gone? Pertussis Trends from and the Potential Early Impact of Tdap Vaccination National Immunization Conference Dallas,
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
National Center for Health Statistics (NCHS) Centers for Disease Control and Prevention.
The Impact of Condom Distribution Programs on Teen Chlamydia and Gonorrhea Rates in Philadelphia, Anjani Parikh, MPH Centers for Disease Control.
CDC EIS Field Assignments Branch New Jersey Department of Health
Overview of National Surveillance for Vaccine-Preventable Diseases
CSTE Applied Epidemiology Fellow
Cynthia F. Hinton, PhD, MS, MPH
Epidemiology Section APHA Tuesday, Nov. 6, 2007
Update on Pertussis – Epidemiology and Vaccination in the U.S.
Jepkoech Kottutt1, Emilia D. Rivadeneira2, Susan Hrapcak2
Evolution of Pertussis Diagnostic Testing in the U.S. :
Pertussis Clinics in Laboratory Medicine
Infertility Prevention Project Coordinator CDC/CCID/NCHHSTP/DSTDP/PTB
Improving Haemophilus influenzae Serotype Reporting
Surveillance of Tuberculosis
Varicella Vaccine Efficacy Estimates
Overview of Pertussis Diagnostics
National Immunization Conference
Presentation transcript:

Amanda E. Faulkner, MPH Surveillance Coordinator 2011 National Immunization Conference March 30, 2011 Zooming in on Pertussis Epidemiology in the United States National Center for Immunization & Respiratory Diseases Meningitis and Vaccine Preventable Diseases Branch

Pertussis Background  Caused by Bordetella pertussis bacteria  Vaccine-preventable and poorly controlled  Reports peak in 3-5 year cycles but vary by geographic regions  Infants at greatest risk for severe illness

It’s Back… Pertussis in

Objectives  Describe U.S. regional pertussis trends during  Age-incidence  Infant case fatality rates  Outbreak-related cases  Discuss challenges in reporting and interpreting surveillance data  Explore ways to improve national pertussis surveillance data

Pertussis Surveillance in the U.S.  Reportable in 1922  National case-based investigations tracked 1979  National Notifiable Disease Surveillance System (NNDSS)  Reports received from all 50 states  Passive surveillance system  Data received  Core variables  Extended variables

CSTE Pertussis Case Definition  Clinical case definition:  Cough > 2 weeks AND  paroxysms, inspiratory whoop, or posttussive vomiting Case Classification ProbableConfirmed - Meets clinical case definition - Culture positive - PCR + clinical case definition - Epi link + clinical case definition

METHODS

Methods  NNDSS data:  2009 final and 2010 provisional datasets  Confirmed, probable, unknown case status Designated by state coding scheme  Cases divided into 9 MMWR geographic reporting regions

MMWR Geographic Regions I: New England II: Mid Atlantic III: E.N. Central IV: W.N. Central V: South Atlantic VI: E.S. Central VII: W.S. Central VIII: Mountain IX: Pacific

Methods  2-year cumulative incidence calculations:  Numerator: Cases reported during  Denominator: 2009 census data estimates  Incidence ranges defined by quartiles  Age groups assessed:  < 1 year  1-4 years  5-6 years  7-10 years  years  years  20+ years

Methods  Infant case fatality rates (CFRs)  Numerator: Deaths reported among cases < 1 year of age  Denominator: All cases among those < 1 year of age  Outbreak-related cases  Used NETSS Outbreak Associated variable  Proportions calculated using only cases with known outbreak status as denominator

RESULTS

U.S. Pertussis Incidence: Source : CDC National Notifiable Disease Surveillance System, 2009 final and 2010 provisional data CDC Wonder Population Estimates (Vintage 2009) *Projection is based on an estimated 30% increase between provisional and final datasets Incidence: Projected 2010 Provisional 2010

Pertussis Incidence by State, * Cumulative incidence is per 100,000 population Source : CDC National Notifiable Disease Surveillance System, 2009 final and 2010 provisional data CDC Wonder Population Estimates (Vintage 2009) Incidence*

Pertussis Incidence by MMWR Region, * Cumulative incidence is per 100,000 population Source : CDC NNDSS, 2009 final and 2010 provisional data, CDC Wonder Population Estimates (Vintage 2009) Incidence* IX: Pacific (Range: ) VIII: Mountain (Range: ) IV: W.N. Central (Range: ) VII: W.S. Central (Range: ) III: E.N. Central (Range: ) VI: E.S. Central (Range: ) V: South Atlantic (Range: ) II: Mid Atlantic (Range: ) I: New England (Range: )

Pertussis Incidence by MMWR Region, * * Cumulative incidence is per 100,000 population Source : CDC NNDSS, 2003 and 2004 final data, CDC Wonder Population Estimates (Vintage 2003) Incidence IX: Pacific VIII: Mountain IV: W.N. Central VII: W.S. Central III: E.N. Central VI: E.S. Central V: South Atlantic II: Mid Atlantic I: New England

Pertussis Incidence by MMWR Region, U.S. Incidence: 12.43

Reported Pertussis Cases by Regional Population,

Pertussis Incidence by Age and Region,

Infant Pertussis Case Fatality Rates by Region, * Denominator for CFR calculations was all reported infant cases.

Proportion of Pertussis Cases Associated with an Outbreak, by Region, *Only includes cases with known outbreak status; 40% of overall reported cases had unknown status.

Summary  Overall pertussis incidence varied significantly by state and region in  Trends in age-specific incidence are similar across regions  Greatest incidence among < 1 year olds  Unexpected regional differences were noted  More populous regions do not necessarily report higher proportions of cases  Infant case fatality rates do not correspond with incidence among infants  Regional proportions of outbreak-related cases vary widely

DISCUSSION

What Do These Findings Mean?  Real differences by region?  Surveillance artifacts?  Surveillance capacity  Testing practices  Provider recognition of pertussis

Factors Impacting NNDSS Pertussis Data Quality  Lack of adherence to CSTE case definition  Incomplete case data  Differences in variable interpretation

Suggestions for Improved Reporting  Appropriate case reporting based on standard CSTE case definition  Complete case data  Standardization of variable interpretation

Conclusions  Differences in regional pertussis epidemiology exist, but interpretation is difficult  Efforts should focus on improving completeness of data and adhering to the CSTE case definition  Better understanding of regional trends in pertussis is key for programmatic and policy decision-making

Acknowledgements Tami Skoff Grace Ejigiri Stacey Martin Tom Clark Nancy Messonnier

For more information please contact Centers for Disease Control and Prevention 1600 Clifton Road NE, Atlanta, GA Telephone, CDC-INFO ( )/TTY: Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Thank you! National Center for Immunization & Respiratory Diseases Meningitis and Vaccine Preventable Diseases Branch